Transfection reagent, TransIT®-BrCa

Supplier: MIRUS

MIR5505 MIR5504 MIR5510 MIR5500 MIR5506
MIRUMIR5505EA 278415 INR
MIRUMIR5505 MIRUMIR5504 MIRUMIR5510 MIRUMIR5500 MIRUMIR5506
Transfection reagent, TransIT®-BrCa
Transfection Reagents

TransIT®-BrCa transfection reagent offers superior DNA transfection of breast cancer cell types.


  • Achieve high expression levels in multiple breast cancer cell types
  • Formulated for low cellular toxicity – maintain cell density and reduce experimental bias
  • Superior transfection efficiency


TransIT®-BrCa transfection reagent is a dedicated breast cancer cell line specific reagent. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental bias. TransIT®-BrCa transfection reagent exhibits higher luciferase expression in breast cancer cells compared to other transfection reagents.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR